» Articles » PMID: 39836612

Freeze the Clock: Earlier Catheter Ablation for Atrial Fibrillation Delivers Better Outcomes

Overview
Journal Europace
Date 2025 Jan 21
PMID 39836612
Authors
Affiliations
Soon will be listed here.
References
1.
Tonnesen J, Ruwald M, Pallisgaard J, Rasmussen P, Johannessen A, Hansen J . Lower Recurrence Rates of Atrial Fibrillation and MACE Events After Early Compared to Late Ablation: A Danish Nationwide Register Study. J Am Heart Assoc. 2024; 13(7):e032722. PMC: 11179760. DOI: 10.1161/JAHA.123.032722. View

2.
Xintarakou A, Tzeis S, Psarras S, Asvestas D, Vardas P . Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps. Europace. 2020; 22(3):342-351. DOI: 10.1093/europace/euaa009. View

3.
Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

4.
Wazni O, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S . Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N Engl J Med. 2020; 384(4):316-324. DOI: 10.1056/NEJMoa2029554. View

5.
Kuniss M, Pavlovic N, Velagic V, Hermida J, Healey S, Arena G . Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021; 23(7):1033-1041. PMC: 8286851. DOI: 10.1093/europace/euab029. View